Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹11 Cr
Revenue (TTM)
₹5 Cr
Net Profit (TTM)
₹-8 Cr
ROE
0 %
ROCE
-4 %
P/E Ratio
--
P/B Ratio
-0.3
Industry P/E
44.74
EV/EBITDA
-55.8
Div. Yield
0 %
Debt to Equity
--
Book Value
₹--
EPS
₹-1.3
Face value
10
Shares outstanding
62,684,919
CFO
58.41 Cr
EBITDA
34.79 Cr
Net Profit
-110.61 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1990
Chairman
--
Managing Director
--
Headquarters
Cuddalore, Tamil Nadu
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Since, TTM earnings of JK Pharmachem Ltd is negative, P/E ratio is not available.
The P/B ratio of JK Pharmachem Ltd is -0.28 times as on 08-Sep-2006, a 109 discount to its peers’ median range of 3.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2005
|
0.00
|
-1.12
|
|
2004
|
0.00
|
-1.54
|
|
2003
|
0.00
|
2.78
|
|
2002
|
2.03
|
0.82
|
|
2001
|
0.00
|
2.55
|
The 52-week high and low of JK Pharmachem Ltd are Rs -- and Rs -- as of 04-Apr-2026.
JK Pharmachem Ltd has a market capitalisation of ₹ 11 Cr as on 08-Sep-2006. As per SEBI classification, it is a company.
Before investing in JK Pharmachem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.